Lower Profits from Polymer Intermediates Dent DSM's Results

DSM says its net and operating profits each decreased 13% in the first quarter of 2012, to €145 million ($188 million) and €200 million from €166 million and €231 million, respectively, in the first quarter of 2011. Ebitda also went down 6% year over year, to €306 million. The decrease in DSM's profits was mainly a result of lower operating profits within the company's polymer intermediates segment as well as the divestment of the DSM elastomers business, the company says. Net sales increased 3%, however, in the first...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers